Compare Cadila Healthcare with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs NOVARTIS - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE NOVARTIS CADILA HEALTHCARE/
NOVARTIS
 
P/E (TTM) x 29.9 902.2 3.3% View Chart
P/BV x 3.6 27.1 13.2% View Chart
Dividend Yield % 1.0 1.6 59.2%  

Financials

 CADILA HEALTHCARE   NOVARTIS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
NOVARTIS
Mar-19
CADILA HEALTHCARE/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs432980 44.1%   
Low Rs306600 51.0%   
Sales per share (Unadj.) Rs128.6198.7 64.7%  
Earnings per share (Unadj.) Rs18.521.0 88.5%  
Cash flow per share (Unadj.) Rs24.422.3 109.6%  
Dividends per share (Unadj.) Rs3.5010.00 35.0%  
Dividend yield (eoy) %0.91.3 74.9%  
Book value per share (Unadj.) Rs101.5307.5 33.0%  
Shares outstanding (eoy) m1,023.7424.69 4,146.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.94.0 72.3%   
Avg P/E ratio x19.937.7 52.9%  
P/CF ratio (eoy) x15.135.5 42.7%  
Price / Book Value ratio x3.62.6 141.7%  
Dividend payout %18.947.7 39.6%   
Avg Mkt Cap Rs m378,17019,508 1,938.6%   
No. of employees `00012.40.6 2,140.8%   
Total wages/salary Rs m21,2411,171 1,813.8%   
Avg. sales/employee Rs Th10,585.08,445.4 125.3%   
Avg. wages/employee Rs Th1,707.82,015.7 84.7%   
Avg. net profit/employee Rs Th1,526.5891.0 171.3%   
INCOME DATA
Net Sales Rs m131,6564,907 2,683.1%  
Other income Rs m2,011783 257.0%   
Total revenues Rs m133,6675,689 2,349.4%   
Gross profit Rs m29,731123 24,210.9%  
Depreciation Rs m5,98632 18,823.9%   
Interest Rs m1,93516 12,169.8%   
Profit before tax Rs m23,821858 2,777.3%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,303340 1,559.7%   
Profit after tax Rs m18,987518 3,667.6%  
Gross profit margin %22.62.5 902.3%  
Effective tax rate %22.339.6 56.2%   
Net profit margin %14.410.6 136.7%  
BALANCE SHEET DATA
Current assets Rs m84,9818,055 1,055.1%   
Current liabilities Rs m73,4251,850 3,968.7%   
Net working cap to sales %8.8126.4 6.9%  
Current ratio x1.24.4 26.6%  
Inventory Days Days7545 165.6%  
Debtors Days Days11034 323.0%  
Net fixed assets Rs m133,493150 89,114.2%   
Share capital Rs m1,024123 829.8%   
"Free" reserves Rs m102,8397,469 1,377.0%   
Net worth Rs m103,8637,592 1,368.1%   
Long term debt Rs m39,4970-   
Total assets Rs m234,8319,824 2,390.3%  
Interest coverage x13.354.9 24.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.60.5 112.3%   
Return on assets %8.95.4 164.0%  
Return on equity %18.36.8 268.1%  
Return on capital %18.311.5 159.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,40458 84,034.7%   
Fx outflow Rs m11,5931,326 874.1%   
Net fx Rs m36,811-1,269 -2,901.5%   
CASH FLOW
From Operations Rs m28,823-1,943 -1,483.6%  
From Investments Rs m-57,3872,742 -2,092.7%  
From Financial Activity Rs m18,846-298 -6,319.9%  
Net Cashflow Rs m-7,105501 -1,417.3%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 8.3 2.0 415.0%  
FIIs % 5.9 1.6 368.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 21.5 51.2%  
Shareholders   44,069 41,647 105.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   VENUS REMEDIES  ORCHID PHARMA LTD  PFIZER  J.B.CHEMICALS  SHASUN PHARMA  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 129 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended their trading session marginally lower.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jun 4, 2020 03:35 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS